Allschwil, Basel-Landschaft, Switzerland · Hybrid
<p>Alentis Therapeutics, the Claudin-1 Company, is on a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committ…
Skills: Clinical Supply Management, Demand Forecasting, Vendor Management, GMP Regulations, GCP Regulations
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Accountable for the management, coordination, and on-time delivery of trial supplies and investigational medicinal products for global clinical trials. This includes developing supply plans, managing external vendors, and ensuring compliance with GMP/GCP regulations.
Requires 3-5 years of experience in clinical trial supply chain or logistics with strong project management skills. Proficiency with IRT/EDC systems and a deep understanding of GMP and GCP regulations are essential.
Alentis Therapeutics, the Claudin-1 Company, is on a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1 and bringing much-needed medicines to patients suffering from solid tumors as well as kidney, liver, and lung fibrosis.
The Clinical Supply Manager is accountable for management, coordination and efficient on-time delivery of trial supplies (including IMP= Investigational Medicinal Product, Placebo, Standard of Care and clinical ancillaries) for global clinical trials to enable the fulfillment of company milestones.
We offer a competitive salary and opportunities for career growth and development. If you are a highly motivated and skilled scientist looking to join a dynamic and innovative team, please submit your CV.
Candidate needs to hold a Swiss working permit or be an EU citizen eligible to work in Switzerland. The work location is Allschwil, Switzerland with 2 days home office possibility.
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis. CLDN1 is a previously unexploited target that plays a key role in the pathology of cancer and fibrotic disease. Alentis is the leading company pioneering CLDN1 ADCs and antibodies to modify and reverse the course of select diseases. Alentis was founded based on ground-breaking research in the laboratory of Prof. Thomas Baumert, MD at the University of Strasbourg and the French National Institute of Health and Medical Research (Inserm). Alentis is headquartered at the pharma-biotech hub in Basel, Switzerland. Visit www.alentis.ch
Offices: Hegenheimermattweg 167a, Allschwil, Basel-Country 4123, CH
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis. CLDN1 is a previously unexploited target that plays a key role in the pathology of cancer and fibrotic disease. Alentis is the leading company pioneering CLDN1 ADCs and antibodies to modify and reverse the course of select diseases. Alentis was founded based on ground-breaking research in the laboratory of Prof. Thomas Baumert, MD at the University of Strasbourg and the French National Institute of Health and Medical Research (Inserm). Alentis is headquartered at the pharma-biotech hub in Basel, Switzerland. Visit www.alentis.ch
Offices: Hegenheimermattweg 167a, Allschwil, Basel-Country 4123, CH
